Theravance Biopharma Inc. (TBPH) is currently at $10.52, up $0.85 or 8.79%
--Would be highest close since Jan. 4, 2024, when it closed at $11.52
--On pace for largest percent increase since April 25, 2022, when it rose 9.39%
--Currently up six of the past seven days
--Currently up five consecutive days; up 24.64% over this period
--Longest winning streak since Nov. 11, 2024, when it rose for five straight trading days
--Best five day stretch since the five days ending Dec. 13, 2021, when it rose 28.43%
--Up 11.8% month-to-date; on pace for best month since Nov. 2024, when it rose 12.26%
--Up 11.8% year-to-date
--Down 75.28% from its all-time closing high of $42.56 on July 7, 2017
--Up 6.16% from 52 weeks ago (Jan. 26, 2024), when it closed at $9.91
--Would be a new 52-week closing high
--Up 37.34% from its 52-week closing low of $7.66 on Aug. 9, 2024
--Traded as high as $10.90; highest intraday level since Jan. 4, 2024, when it hit $11.71
--Up 12.72% at today's intraday high; largest intraday percent increase since Nov. 13, 2024, when it rose as much as 15.15%
All data as of 1:59:13 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 24, 2025 14:01 ET (19:01 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.